Tag: NHS

The findings of a study examining 39 years of breast cancer death rates have hit the headlines, with The Guardian reporting that, ‘Breast cancer screening not shown to reduce deaths.’ The value of breast cancer screening has been the subject of debate for many years.

While the overall reporting on the findings of the review was accurate, most of the headlines focused on the negative findings – the problem of overdiagnosis. The NHS shares its views on the findings of the independent panel that reviewed the benefits and harms of breast cancer screening in the UK.
In the article “Breast cancer screening may not reduce deaths“, the NHS responds to the following questions:

• Where did the story come from?
• What kind of research was this?
• What did the research involve?
• What were the basic results?
• How did the researchers interpret the results?

Analysis by Bazian, NHS Choices

Great except that I won’t get an “invitation” before I turn 50 even though a recent study concluded that DES Daughters over the age of 40 are at a significantly increased risk for breast cancer …

UK Guidelines: Read Diethylstilbestrol (DES) exposed women and breast screening and about being breast aware in the United Kingdom

In Australia,  there are problems too, on the matter of acquiring annual breast screening… Read Our Breast Screening Behind The Scenes by Carol Devine.

More DES DiEthylStilbestrol Resources

• DES studies on cancers and screening.
• DES studies on epigenetics and transgenerational effects.
• DES studies on fertility and pregnancy.
• DES studies on gender identity and psychological health.
• DES studies on in-utero exposure to DES and side-effects.
• DES studies on the genital tract.
• Papers on DES lawsuits.
• DES videos and posts tagged DES, the DES-exposed, DES victims.